This proposal is to continue research on our proposal that iron is involved
in certain toxicities and pathologies. We have proposed that the iron
storage protein ferritin may be the source of this iron. Superoxide, and
especially organic radicals, release iron from ferritin. This iron will
catalyze the oxidation of tissues including lipid peroxidation. We propose
that this may be a mechanism by which chemicals that redox cycle may be
toxic. We also propose that ferritin may be a protective protein given an
efficient method to place the iron into ferritin. We propose that
ceruloplasmin may accomplish this as it is an effective ferroxidase which
does not release partially reduced species of oxygen such as hydrogen
peroxide. Thus, a combination of ferritin and ceruloplasmin may have
antioxidant activity. Evidence is mounting that ceruloplasmin is an
important intracellular, extrahepatic enzyme. We propose to further
investigate this hypothesis. We are also going to investigate the proposal
that both ferritin and ceruloplasmin may be induced by redox cycling
toxins. We also have to further investigate ferritin as we have found that
it differs in susceptibility to iron release by paraquat and adriamycin
depending upon the tissue from which it was isolated. We are proposing to
test the hypothesis that this is due to different content of heavy vs light
peptide chains. We also propose to test the hypothesis that some complex
may exist between ferritin and ceruloplasmin. Finally, we propose to
extend our research to investigate enzymes that have been proposed to have
"oxidase" activity. We will start with the enzyme gamma-glutamyl
transpeptidase. We propose that the products of the enzyme as it is
usually assayed are good iron reductants and that subsequent oxidation of
this iron is the source of the "oxidase" activity associated with this
enzyme. This iron is usually well controlled in physiological conditions
so the "oxidase" activity of gamma-glutamyl transpeptidase is probably not
of physiological significance except in unusual situations.
National Institute of Environmental Health Sciences
CFDA Code
DUNS Number
072983455
UEI
SPE2YDWHDYU4
Project Start Date
01-May-1989
Project End Date
30-June-1995
Budget Start Date
01-July-1994
Budget End Date
30-June-1995
Project Funding Information for 1994
Total Funding
$129,639
Direct Costs
$94,627
Indirect Costs
$35,012
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Environmental Health Sciences
$129,639
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01ES005056-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01ES005056-06
Patents
No Patents information available for 5R01ES005056-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01ES005056-06
Clinical Studies
No Clinical Studies information available for 5R01ES005056-06
News and More
Related News Releases
No news release information available for 5R01ES005056-06
History
No Historical information available for 5R01ES005056-06
Similar Projects
No Similar Projects information available for 5R01ES005056-06